Maynard Um
-
-
-
-
-
-
-
Omeros (OMER) Misses Q1 EPS by 12c
-
-
-
-
-
-
-
Increasing unusual put option volume: XLB OMER IVVD WIX HP JCI BOX
-
-
-
-
-
-
-
Omeros publishes study on narsoplimab survival outcomes for TA-TMA patients
-
-
-
-
-
-
-
Omeros (OMER) Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program
-
-
-
-
-
-
-
Omeros' (OMER) Narsoplimab Meets its Pivotal Trial Primary Endpoint
-
-
-
-
-
-
402,277 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

